Losing weight and sustaining a healthy weight are notoriously difficult. If you’re struggling to reach your weight goals, you ...

Spread the loveIntroduction In today’s market, where body sculpting and weight management products continue to gain ...

Weight loss drugs like Ozempic and Wegovy are used by over 15 million adults in the U.S., or 4.5% of the population. Despite ...

Combining elements of four hormones into a single drug, researchers hope a next-generation weight loss drug will address not ...

What drives us is the idea that we can design a single drug to treat obesity and simultaneously mitigate the risk of developing a long list of health problems plaguing society,” says Krishna Kumar.

Amplifye, a startup led by former Amyris CEO John Melo, has launched its first product: an enzyme claimed to optimize protein ...

Ascendis Pharma has reported week 26 interim analysis outcomes from the Phase II COACH Trial assessing TransCon CNP and ...

The combination of TransCon hGH and TransCon CNP demonstrated accelerated improvement in body proportionality at Week 26, ...

Semaglutide, a synthetic analog of glucagon-like peptide-1 (GLP-1), has garnered attention for its intriguing properties and potential implications in various r ...

CLARE Butler struggled with her weight for most of her adult life. As an emotional eater, food was her go-to whenever she ...